Annual Total Long Term Liabilities
$587.76 K
-$97.50 K-14.23%
31 December 2023
Summary:
Sunshine Biopharma annual total long term liabilities is currently $587.76 thousand, with the most recent change of -$97.50 thousand (-14.23%) on 31 December 2023. During the last 3 years, it has fallen by -$361.24 thousand (-38.07%). SBFMW annual total long term liabilities is now -69.07% below its all-time high of $1.90 million, reached on 31 December 2021.SBFMW Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$489.03 K
-$22.61 K-4.42%
30 September 2024
Summary:
Sunshine Biopharma quarterly total long term liabilities is currently $489.03 thousand, with the most recent change of -$22.61 thousand (-4.42%) on 30 September 2024. Over the past year, it has dropped by -$109.69 thousand (-18.32%). SBFMW quarterly long term liabilities is now -84.74% below its all-time high of $3.20 million, reached on 30 September 2021.SBFMW Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.2% | -18.3% |
3 y3 years | -38.1% | -84.7% |
5 y5 years | +102.8% | +100.0% |
SBFMW Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -69.1% | at low | -84.7% | |
5 y | 5 years | -69.1% | -84.7% | ||
alltime | all time | -69.1% | -84.7% |
Sunshine Biopharma Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $489.03 K(-4.4%) |
June 2024 | - | $511.63 K(-6.2%) |
Mar 2024 | - | $545.70 K(-7.2%) |
Dec 2023 | $587.76 K(-14.2%) | $587.76 K(-1.8%) |
Sept 2023 | - | $598.72 K(-6.4%) |
June 2023 | - | $639.88 K(-2.5%) |
Mar 2023 | - | $656.17 K(-4.2%) |
Dec 2022 | $685.26 K(-63.9%) | $685.26 K(>+9900.0%) |
Sept 2022 | - | $0.00(0.0%) |
June 2022 | - | $0.00(0.0%) |
Mar 2022 | - | $0.00(-100.0%) |
Dec 2021 | $1.90 M(+100.2%) | $1.90 M(-40.7%) |
Sept 2021 | - | $3.20 M(+56.0%) |
June 2021 | - | $2.05 M(-1.1%) |
Mar 2021 | - | $2.08 M(+119.0%) |
Dec 2020 | $949.01 K(>+9900.0%) | $949.01 K(+165.4%) |
Sept 2020 | - | $357.55 K(+465.4%) |
June 2020 | - | $63.23 K(>+9900.0%) |
Mar 2020 | - | $0.00(0.0%) |
Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2019 | - | $0.00(0.0%) |
June 2019 | - | $0.00(-100.0%) |
Mar 2019 | - | $338.97 K(+16.9%) |
Dec 2018 | $289.85 K(+263.6%) | $289.85 K(-7.3%) |
Sept 2018 | - | $312.57 K(+0.9%) |
June 2018 | - | $309.67 K(-3.8%) |
Mar 2018 | - | $322.02 K(+304.0%) |
Dec 2017 | $79.71 K(>+9900.0%) | $79.71 K(>+9900.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2016 | - | $0.00(-100.0%) |
June 2016 | - | $30.00(>+9900.0%) |
Mar 2016 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2015 | - | $0.00(0.0%) |
June 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2014 | - | $0.00(0.0%) |
June 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2013 | - | $0.00(0.0%) |
June 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2012 | - | $0.00(0.0%) |
June 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2011 | - | $0.00(0.0%) |
June 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2010 | - | $0.00(0.0%) |
June 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | - |
Oct 2009 | - | $0.00(0.0%) |
July 2009 | - | $0.00(0.0%) |
Apr 2009 | - | $0.00(0.0%) |
Jan 2009 | - | $0.00(0.0%) |
Oct 2008 | - | $0.00(0.0%) |
July 2008 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2008 | - | $0.00(0.0%) |
Jan 2008 | - | $0.00(0.0%) |
Oct 2007 | - | $0.00 |
July 2007 | $0.00 | - |
FAQ
- What is Sunshine Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma annual total long term liabilities year-on-year change?
- What is Sunshine Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly long term liabilities year-on-year change?
What is Sunshine Biopharma annual total long term liabilities?
The current annual total long term liabilities of SBFMW is $587.76 K
What is the all time high annual total long term liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total long term liabilities is $1.90 M
What is Sunshine Biopharma annual total long term liabilities year-on-year change?
Over the past year, SBFMW annual total long term liabilities has changed by -$97.50 K (-14.23%)
What is Sunshine Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of SBFMW is $489.03 K
What is the all time high quarterly long term liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total long term liabilities is $3.20 M
What is Sunshine Biopharma quarterly long term liabilities year-on-year change?
Over the past year, SBFMW quarterly total long term liabilities has changed by -$109.69 K (-18.32%)